Lorusso D, Martin-Babau J, Backes F, Ginesta MPB, et al. Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial. Lancet 2026 Oct 26:S0140-6736(26)02099-4. doi: 10.1016/S0140-6736(26)02099.
PMID: 42933460